$RGC News

Regencell Bioscience shares are trading lower after the company announced it entered a sales agreement for up to $500 million of shares under an at-the-market offering program.

Regencell Bioscience shares are trading lower after the company announced it entered a sales agreement for up to $500 million of shares under an at-the-market offering program.

Regencell Bioscience Plans To Sell Up To $500M In Stock Over Time

Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential

These 3 Growth Stocks Won’t Be This Cheap Forever

This $14 Billion Meme Stock Says It Is Developing a Herbal Remedy for Autism

Regencell Bioscience Shares Halted On Circuit Breaker To The Downside, Stock Now Down -31.90%

Regencell Bioscience Shares Halted On Circuit Breaker To The Downside, Stock Now Down -16.62%

Regencell Bioscience Shares Resume Trade, Stock Now Down ~-9%

Regencell Bioscience: Cutting Costs Isn't Growth, It's Survival

Regencell Bioscience: Material Weaknesses Add To Woes

This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)

Regencell Bioscience shares are trading lower after the company received a subpoena indicating the DOJ is conducting an investigation into the trading in its Ordinary Shares. Additionally, the company said there is substantial doubt about its ability to continue as a going concern.

Regencell Bioscience Holdings Limited (RGC) Added to S&P Global BMI Index Amid Positive ADHD/ASD Trial Results

Regencell Bioscience Holdings (RGC) Climbs 11% Over Last Week

Regencell Bioscience: Down 80%, More Downside Is Likely

Regencell Bioscience (RGC) Nosedives 19.8% on Profit-Taking

Regencell Bioscience Stock Volatility Continues Monday

Regencell Bioscience H1 EPS $(0.36) Up From $(0.42) YoY

Regencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can Explain